Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sushama Talegaonkar

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
AAPS Pharmscitech|February 27, 2019
Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal PermeabilitySushama Talegaonkar, Arundhati Bhattacharyya
Molecular and Cellular Endocrinology|November 12, 2016
Effects of raloxifene against letrozole-induced bone loss in chemically-induced model of menopause in miceAbul Kalam, Sushama Talegaonkar, Divya Vohora
Fundamental & Clinical Pharmacology|June 10, 2016
Differential profile of letrozole and exemestane on bone turnover markers in vinylcyclohexene diepoxide treated ovotoxic female miceAbul Kalam, Sushama Talegaonkar, Divya Vohora
Data in Brief|January 6, 2017
Data of aromatase inhibitors alone and in combination with raloxifene on microarchitecture of lumbar vertebrae and strength test in femoral diaphysis of VCD treated ovotoxic miceAbul Kalam, Sushama Talegaonkar, Divya Vohora
Nanotechnology|December 11, 2012
A logical approach to optimize the nanostructured lipid carrier system of irinotecan: efficient hybrid design methodologyLalit Mohan Negi, Manu Jaggi, Sushama Talegaonkar
Colloids and Surfaces. B, Biointerfaces|July 16, 2013
Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-Glycoprotein modulationLalit Mohan Negi, Mohammad Tariq, Sushama Talegaonkar
International Journal of Pharmaceutics|December 19, 2013
Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriersLalit Mohan Negi, Manu Jaggi, Sushama Talegaonkar
Journal of Drug Targeting|October 23, 2009
Niosomes in sustained and targeted drug delivery: some recent advancesAdnan Azeem, Md Khalid Anwer, Sushama Talegaonkar
Medical Hypotheses|January 7, 2014
Addressing the potential toxicities of the non-specific P-glycoprotein modulation by amalgamation with targeted approach in MDR tumorsLalit Mohan Negi, Manu Jaggi, Sushama Talegaonkar
Pharmaceutical Nanotechnology|April 10, 2019
Nanocrystalization: An Emerging Technology to Enhance the Bioavailability of Poorly Soluble DrugsKavita Joshi, Akhilesh Chandra, Keerti Jain, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
AAPS Pharmscitech|February 27, 2019
Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal PermeabilitySushama Talegaonkar, Arundhati Bhattacharyya
Molecular and Cellular Endocrinology|November 12, 2016
Effects of raloxifene against letrozole-induced bone loss in chemically-induced model of menopause in miceAbul Kalam, Sushama Talegaonkar, Divya Vohora
Fundamental & Clinical Pharmacology|June 10, 2016
Differential profile of letrozole and exemestane on bone turnover markers in vinylcyclohexene diepoxide treated ovotoxic female miceAbul Kalam, Sushama Talegaonkar, Divya Vohora
Data in Brief|January 6, 2017
Data of aromatase inhibitors alone and in combination with raloxifene on microarchitecture of lumbar vertebrae and strength test in femoral diaphysis of VCD treated ovotoxic miceAbul Kalam, Sushama Talegaonkar, Divya Vohora
Nanotechnology|December 11, 2012
A logical approach to optimize the nanostructured lipid carrier system of irinotecan: efficient hybrid design methodologyLalit Mohan Negi, Manu Jaggi, Sushama Talegaonkar
Colloids and Surfaces. B, Biointerfaces|July 16, 2013
Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-Glycoprotein modulationLalit Mohan Negi, Mohammad Tariq, Sushama Talegaonkar
International Journal of Pharmaceutics|December 19, 2013
Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriersLalit Mohan Negi, Manu Jaggi, Sushama Talegaonkar
Journal of Drug Targeting|October 23, 2009
Niosomes in sustained and targeted drug delivery: some recent advancesAdnan Azeem, Md Khalid Anwer, Sushama Talegaonkar
Medical Hypotheses|January 7, 2014
Addressing the potential toxicities of the non-specific P-glycoprotein modulation by amalgamation with targeted approach in MDR tumorsLalit Mohan Negi, Manu Jaggi, Sushama Talegaonkar
Pharmaceutical Nanotechnology|April 10, 2019
Nanocrystalization: An Emerging Technology to Enhance the Bioavailability of Poorly Soluble DrugsKavita Joshi, Akhilesh Chandra, Keerti Jain, et al.
Pageof 11